Efficacy and safety of linagliptin as monotherapy or add-on treatment in Asian patients with suboptimal glycemic control: a pooled analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of linagliptin as monotherapy or add-on treatment in Asian patients with suboptimal glycemic control: a pooled analysis

Published:2014-10-08 Issue:1 Volume:31 Page:99-106
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Zeng Zhengpei¹,Choi Dong Seop²,Mohan Viswanathan³,Emser Angela⁴,Siddiqui Kamran⁵,Gong Yan⁴,Patel Sanjay⁶,Woerle Hans-Juergen⁴

Affiliation:

1. aPeking Union Medical College Hospital, Beijing, China

2. bKorea University College of Medicine, Seoul, Korea

3. cMadras Diabetes Research Foundation and Dr Mohan’s Diabetes Specialities Centre, Chennai, India

4. dBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany

5. eBoehringer Ingelheim Singapore Pte. Ltd, Singapore, Republic of Singapore

6. fBoehringer Ingelheim Ltd, Bracknell, UK

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2014.964856

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study;Diabetes, Obesity and Metabolism;2021-02-07

2. Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial;Diabetology International;2019-10-22

3. Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial;Journal of Diabetes Investigation;2017-11-13

4. Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials;Advances in Therapy;2017-08-17

5. Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes;Diabetes Research and Clinical Practice;2017-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3